美国 · SEC FORM 4
Stoke Therapeutics, Inc.
STOK · Nasdaq · CIK 0001623526 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
20 同一窗口内观察到的 Form 4 交易行
17 sales · 3 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2020-11-24 · Harrison Seth Loring.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 11,505,410
- 上期报告
- 11,150,236
- 日均成交量
- 1,131,259
- 回补天数
- 10.2
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
104 transaction lines in the latest 365-day window; 366 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Allan Jonathan | 卖出 (S) | Common Stock | 627 | USD 26.33 | USD 16,509 | SEC 申报 ↗ |
| 2026-10-01 | Ticho Barry | 卖出 (S) | Common Stock | 1,051 | USD 26.16 | USD 27,494 | SEC 申报 ↗ |
| 2026-09-01 | Ticho Barry | 卖出 (S) | Common Stock | 5,545 | USD 30.67 | USD 170,058 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Allan Jonathan | 卖出 (S) | Common Stock | 627 | USD 26.33 | USD 16,509 | SEC 申报 ↗ |
| 2026-10-01 | Ticho Barry | 卖出 (S) | Common Stock | 1,051 | USD 26.16 | USD 27,494 | SEC 申报 ↗ |
| 2026-09-01 | Ticho Barry | 卖出 (S) | Common Stock | 5,545 | USD 30.67 | USD 170,058 | SEC 申报 ↗ |
| 2026-08-18 | Ticho Barry | 卖出 (S) | Common Stock | 4,767 | USD 32.03 | USD 152,703 | SEC 申报 ↗ |
| 2026-08-18 | Kaye Edward M. MD | 卖出 (S) | Common Stock | 12,567 | USD 32.03 | USD 402,563 | SEC 申报 ↗ |
| 2026-08-18 | Allan Jonathan | 卖出 (S) | Common Stock | 2,861 | USD 32.03 | USD 91,647 | SEC 申报 ↗ |
| 2026-08-14 | Ticho Barry | 期权行权／转换 (M) | Common Stock | 10,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-14 | Kaye Edward M. MD | 期权行权／转换 (M) | Common Stock | 26,250 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-14 | Allan Jonathan | 期权行权／转换 (M) | Common Stock | 6,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-03 | Ticho Barry | 卖出 (S) | Common Stock | 7,176 | USD 29.04 | USD 208,380 | SEC 申报 ↗ |
| 2026-07-01 | Ticho Barry | 卖出 (S) | Common Stock | 7,228 | USD 32.66 | USD 236,102 | SEC 申报 ↗ |
| 2026-06-16 | Allan Jonathan | 卖出 (S) | Common Stock | 1,457 | USD 29.95 | USD 43,637 | SEC 申报 ↗ |
| 2026-06-01 | Ticho Barry | 卖出 (S) | Common Stock | 1,795 | USD 30.58 | USD 54,891 | SEC 申报 ↗ |
| 2026-05-01 | Ticho Barry | 卖出 (S) | Common Stock | 2,243 | USD 32.79 | USD 73,548 | SEC 申报 ↗ |
| 2026-04-01 | Ticho Barry | 卖出 (S) | Common Stock | 1,838 | USD 32.66 | USD 60,029 | SEC 申报 ↗ |
| 2026-03-20 | Allan Jonathan | 卖出 (S) | Common Stock | 9,293 | USD 33.69 | USD 313,079 | SEC 申报 ↗ |
| 2026-03-19 | Ticho Barry | 卖出 (S) | Common Stock | 1,461 | USD 29.99 | USD 43,815 | SEC 申报 ↗ |
| 2026-03-19 | Ticho Barry | 期权行权／转换 (M) | Common Stock | 1,365 | USD 2.19 | USD 2,989 | SEC 申报 ↗ |
| 2026-03-18 | Ticho Barry | 卖出 (S) | Common Stock | 6,686 | USD 31.34 | USD 209,546 | SEC 申报 ↗ |
| 2026-03-18 | Leggett Thomas | 卖出 (S) | Common Stock | 2,382 | USD 31.34 | USD 74,655 | SEC 申报 ↗ |
| 2026-03-18 | Hoitt Jason | 卖出 (S) | Common Stock | 1,931 | USD 31.34 | USD 60,520 | SEC 申报 ↗ |
| 2026-03-18 | Allan Jonathan | 卖出 (S) | Common Stock | 4,628 | USD 31.34 | USD 145,047 | SEC 申报 ↗ |
| 2026-03-17 | Ticho Barry | 卖出 (S) | Common Stock | 6,164 | USD 33.01 | USD 203,465 | SEC 申报 ↗ |
| 2026-03-17 | Leggett Thomas | 卖出 (S) | Common Stock | 2,196 | USD 33.01 | USD 72,487 | SEC 申报 ↗ |
| 2026-03-17 | Hoitt Jason | 卖出 (S) | Common Stock | 1,781 | USD 33.01 | USD 58,789 | SEC 申报 ↗ |
| 2026-03-17 | Allan Jonathan | 卖出 (S) | Common Stock | 4,267 | USD 33.01 | USD 140,848 | SEC 申报 ↗ |
| 2026-03-15 | Ticho Barry | 期权行权／转换 (M) | Common Stock | 33,850 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-15 | Leggett Thomas | 期权行权／转换 (M) | Common Stock | 14,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-15 | Kaye Edward M. MD | 期权行权／转换 (M) | Common Stock | 61,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-15 | Hoitt Jason | 期权行权／转换 (M) | Common Stock | 10,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | STOK |
| CIK | 0001623526 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 366 transaction lines from 2020-03-02 to 2026-10-02 2 P purchase lines · 245 S sale lines · 119 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.